Shah Nikita, Executive Vice President of Amneal Pharmaceuticals ($AMRX), sold about $4.2 million worth of company shares across six open market transactions over the past year. His most recent sale occurred on November 12, 2025. These sales rank 2,174th among over 11,600 insiders in our database, where the average is about $8.6 million across roughly six trades per person. Nikita made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 23544 | $0.00 | 210,566.0000 | 324,754,000 | 12.59% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 22982 | $13.31 | 187,022.0000 | 324,754,000 | 10.94% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 45871 | $0.00 | 210,004.0000 | 324,754,000 | 27.95% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18502 | $13.31 | 164,133.0000 | 324,754,000 | 10.13% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 36232 | $0.00 | 182,635.0000 | 324,754,000 | 24.75% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 35880 | $0.00 | 71,760.0000 | 324,754,000 | 33.33% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Performance-Based Restricted Stock Units | 366972 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.11% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 23544 | $0.00 | 70,634.0000 | 324,754,000 | 25.00% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 45871 | $0.00 | 45,872.0000 | 324,754,000 | 50.00% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 36232 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 17976 | $13.30 | 399,793.0000 | 324,754,000 | 4.30% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 35880 | $0.00 | 417,769.0000 | 324,754,000 | 9.40% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 183853 | $13.31 | 381,889.0000 | 324,754,000 | 32.50% | 0.06% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 366972 | $0.00 | 565,742.0000 | 324,754,000 | 184.62% | 0.11% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 11796 | $13.31 | 198,770.0000 | 324,754,000 | 5.60% | 0.00% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Performance-Based Restricted Stock Units | 65359 | $0.00 | 65,359.0000 | 324,754,000 | 9999.99% | 0.02% |
| Nov. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Stock Option (Right to Buy) | 95525 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.03% |
| Nov. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 95525 | $2.75 | 278,259.0000 | 324,754,000 | 52.28% | 0.03% |
| Nov. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Stock Option (Right to Buy) | 36331 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.01% |
| Nov. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 36331 | $2.75 | 182,734.0000 | 324,754,000 | 24.82% | 0.01% |
| Nov. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 131856 | $11.92 | 146,403.0000 | 324,754,000 | 47.39% | 0.04% |
| Aug. 22, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 114492 | $9.66 | 152,743.0000 | 308,978,000 | 42.84% | 0.04% |
| Aug. 25, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 6340 | $9.50 | 146,403.0000 | 308,978,000 | 4.15% | 0.00% |
| Aug. 14, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 71694 | $9.29 | 267,235.0000 | 308,978,000 | 21.15% | 0.02% |
| Aug. 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 50000 | $9.04 | 338,929.0000 | 308,978,000 | 12.86% | 0.02% |
| May 16, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 49140 | $7.58 | 388,929.0000 | 308,978,000 | 11.22% | 0.02% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 35879 | $0.00 | 456,422.0000 | 308,978,000 | 8.53% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 36232 | $0.00 | 345,871.0000 | 308,978,000 | 11.70% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18533 | $8.76 | 327,338.0000 | 308,978,000 | 5.36% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 45872 | $0.00 | 373,210.0000 | 308,978,000 | 14.01% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 23464 | $8.76 | 349,746.0000 | 308,978,000 | 6.29% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 144928 | $0.00 | 494,674.0000 | 308,978,000 | 41.44% | 0.05% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 74131 | $8.76 | 420,543.0000 | 308,978,000 | 14.99% | 0.02% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18353 | $8.84 | 438,069.0000 | 308,978,000 | 4.02% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 36232 | $0.00 | 36,232.0000 | 308,978,000 | 50.00% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 45872 | $0.00 | 91,743.0000 | 308,978,000 | 33.33% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Performance-Based Restricted Stock Units | 144928 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.05% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Performance-Based Restricted Stock Units | 188356 | $0.00 | 188,356.0000 | 308,978,000 | 9999.99% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Restricted Stock Units | 94178 | $0.00 | 94,178.0000 | 308,978,000 | 9999.99% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 35879 | $0.00 | 107,640.0000 | 308,978,000 | 50.00% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 10985 | $8.67 | 309,639.0000 | 308,978,000 | 3.43% | 0.00% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 28958 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 28958 | $0.00 | 320,624.0000 | 308,978,000 | 9.93% | 0.01% |
| Aug. 14, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | S | Class A Common Stock | 100000 | $7.75 | 291,666.0000 | 176,136,000 | 25.53% | 0.06% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 36232 | $0.00 | 386,930.0000 | 176,136,000 | 10.33% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18153 | $5.47 | 368,777.0000 | 176,136,000 | 4.69% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 45871 | $0.00 | 414,648.0000 | 176,136,000 | 12.44% | 0.03% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 22982 | $5.47 | 391,666.0000 | 176,136,000 | 5.54% | 0.01% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 28957 | $0.00 | 28,958.0000 | 176,136,000 | 50.00% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 36232 | $0.00 | 72,464.0000 | 176,136,000 | 33.33% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 45871 | $0.00 | 137,615.0000 | 176,136,000 | 25.00% | 0.03% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Restricted Stock Units | 143519 | $0.00 | 143,519.0000 | 176,136,000 | 9999.99% | 0.08% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Performance-Based Restricted Stock Units | 287038 | $0.00 | 287,038.0000 | 176,136,000 | 9999.99% | 0.16% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 28957 | $0.00 | 365,879.0000 | 176,136,000 | 8.59% | 0.02% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 15181 | $5.47 | 350,698.0000 | 176,136,000 | 4.15% | 0.01% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 35620 | $0.00 | 355,592.0000 | 176,136,000 | 11.13% | 0.02% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18670 | $5.71 | 336,922.0000 | 176,136,000 | 5.25% | 0.01% |
| Feb. 27, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 35620 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 18064 | $1.92 | 319,972.0000 | 150,944,000 | 5.34% | 0.01% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 36232 | $0.00 | 108,696.0000 | 150,944,000 | 25.00% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 36232 | $0.00 | 338,036.0000 | 150,944,000 | 12.01% | 0.02% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Performance-Based Restricted Stock Units | 366972 | $0.00 | 366,972.0000 | 150,944,000 | 9999.99% | 0.24% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | A | Restricted Stock Units | 183486 | $0.00 | 183,486.0000 | 150,944,000 | 9999.99% | 0.12% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 11729 | $0.00 | 294,905.0000 | 150,944,000 | 4.14% | 0.01% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 6504 | $2.09 | 288,401.0000 | 150,944,000 | 2.21% | 0.00% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 28958 | $0.00 | 57,915.0000 | 150,944,000 | 33.33% | 0.02% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 11729 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.01% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 15555 | $2.09 | 301,804.0000 | 150,944,000 | 4.90% | 0.01% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 28958 | $0.00 | 317,359.0000 | 150,944,000 | 10.04% | 0.02% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Restricted Stock Units | 35620 | $0.00 | 35,620.0000 | 150,944,000 | 50.00% | 0.02% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | M | Class A Common Stock | 35620 | $0.00 | 302,928.0000 | 150,944,000 | 13.33% | 0.02% |
| Feb. 27, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Shah Nikita | Executive Vice President | F | Class A Common Stock | 19752 | $2.16 | 283,176.0000 | 150,944,000 | 6.52% | 0.01% |